Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V de las Heras

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2007
Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish populationV De Las Heras, C De Andrés, N Téllez, et al.
European Journal of Neurology|January 26, 2007
Interferon-beta treatment and active replication of the JC virus in relapsing-remitting multiple sclerosis patientsR Alvarez-Lafuente, M García-Montojo, V De Las Heras, et al.
Neurologia (Barcelona, Spain)|March 28, 2008
[Spontaneous spinal epidural hematoma]M E García Garcia, V de Las Heras, M Kurtis Urra, et al.
Acta Neurologica Scandinavica|May 22, 2009
CD46 expression and HHV-6 infection in patients with multiple sclerosisR Alvarez-Lafuente, M Garcia-Montojo, V De Las Heras, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
The 795CT polymorphism in osteopontin gene is not associated with multiple sclerosis in a Spanish populationA Mas, A Martínez, V de las Heras, et al.
Journal of Neuroimmunology|January 25, 2006
An IFNG polymorphism is associated with interferon-beta response in Spanish MS patientsA Martínez, V de las Heras, A Mas Fontao, et al.
European Journal of Neurology|April 27, 2011
Human herpesvirus 6 and effectiveness of interferon β1b in multiple sclerosis patientsM Garcia-Montojo, V De Las Heras, M Dominguez-Mozo, et al.
European Journal of Neurology|January 7, 2010
Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: a two-year follow-up studyM Garcia-Montojo, M I Dominguez-Mozo, V de las Heras, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 21, 2008
Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patientsR Alvarez-Lafuente, M García-Montojo, V De Las Heras, et al.
Acta Neurologica Scandinavica|March 21, 2002
Prevalence of herpesvirus DNA in MS patients and healthy blood donorsR Alvarez-Lafuente, C Martín-Estefanía, V de las Heras, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 12, 2007
Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish populationV De Las Heras, C De Andrés, N Téllez, et al.
European Journal of Neurology|January 26, 2007
Interferon-beta treatment and active replication of the JC virus in relapsing-remitting multiple sclerosis patientsR Alvarez-Lafuente, M García-Montojo, V De Las Heras, et al.
Neurologia (Barcelona, Spain)|March 28, 2008
[Spontaneous spinal epidural hematoma]M E García Garcia, V de Las Heras, M Kurtis Urra, et al.
Acta Neurologica Scandinavica|May 22, 2009
CD46 expression and HHV-6 infection in patients with multiple sclerosisR Alvarez-Lafuente, M Garcia-Montojo, V De Las Heras, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
The 795CT polymorphism in osteopontin gene is not associated with multiple sclerosis in a Spanish populationA Mas, A Martínez, V de las Heras, et al.
Journal of Neuroimmunology|January 25, 2006
An IFNG polymorphism is associated with interferon-beta response in Spanish MS patientsA Martínez, V de las Heras, A Mas Fontao, et al.
European Journal of Neurology|April 27, 2011
Human herpesvirus 6 and effectiveness of interferon β1b in multiple sclerosis patientsM Garcia-Montojo, V De Las Heras, M Dominguez-Mozo, et al.
European Journal of Neurology|January 7, 2010
Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: a two-year follow-up studyM Garcia-Montojo, M I Dominguez-Mozo, V de las Heras, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 21, 2008
Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patientsR Alvarez-Lafuente, M García-Montojo, V De Las Heras, et al.
Acta Neurologica Scandinavica|March 21, 2002
Prevalence of herpesvirus DNA in MS patients and healthy blood donorsR Alvarez-Lafuente, C Martín-Estefanía, V de las Heras, et al.
Pageof 3